117. J Inorg Biochem. 2018 Jul 4;187:1-13. doi: 10.1016/j.jinorgbio.2018.06.008. [Epubahead of print]Pro-apoptotic activity of ruthenium 1-methylimidazole complex on non-small celllung cancer.Dias JSM(1), Silva HVR(1), Ferreira-Silva GÁ(2), Ionta M(2), Corrêa CC(3),Almeida F(4), Colina-Vegas L(5), Barbosa MIF(6), Doriguetto AC(7).Author information: (1)Instituto de Química, Universidade Federal de Alfenas, CEP 37130-001 Alfenas, MG, Brazil.(2)Departamento de Ciências Biomédicas, Universidade Federal de Alfenas, CEP37130-001, Alfenas, MG, Brazil.(3)Departamento de Química, ICE Universidade Federal de Juiz de Fora, CEP36036-900 Juiz de Fora, MG, Brazil.(4)Instituto de Ciências Biomédicas - icb4, Universidade de São Paulo, CEP05508-900 São Paulo, SP, Brazil.(5)Departamento de Química, Universidade Federal de São Carlos, CEP 13565-905 SãoCarlos, SP, Brazil.(6)Instituto de Química, Universidade Federal de Alfenas, CEP 37130-001 Alfenas, MG, Brazil. Electronic address: mariliaifrazaob@gmail.com.(7)Instituto de Química, Universidade Federal de Alfenas, CEP 37130-001 Alfenas, MG, Brazil. Electronic address: doriguetto@unifal-mg.edu.br.Herein, novel ruthenium(II) complexes containing 1-methylimidazole as a ligandwere obtained with the following formulas: [RuCl(1Meim)(dppb)(bpy)]Cl (1),[RuCl(1Meim)(dppb)(4,4'-DMbpy)]Cl (2), [RuCl(1Meim)(dppb)(5,5'-DMbpy)]Cl (3) and [RuCl(1Meim)(dppb)(phen)]Cl (4) where, 1Meim = 1-methylimidazole,dppb = 1,4-Bis(diphenylphosphino)butane, bpy = 2,2'-bipyridine,4,4'-DMbpy = 4,4'-dimethyl-2,2'-bipyridine,5,5'-DMbpy = 5,5'-dimethyl-2,2'-bipyridine and phen = 1,10-phenanthroline.Additionally, crystal structures containing the cations of (1) and (3) wereobtained when the counter ion was exchanged, leading to the formation of[RuCl(1Meim)(dppb)(bpy)]PF6 (5) and [RuCl(1Meim)(dppb)(5,5'-DMbpy)]PF6 methanolsolvate (6) where PF6 = hexafluorophosphate, showing one 1-methylimidazolemolecule coordinated through the imidazole nitrogen, as expected. The complexeswere characterized by elemental analysis, molar conductivity, infrared and UV-Visspectroscopy, 1H, 13C{1H} and 31P{1H} NMR, mass spectrometry and cyclicvoltammetry. The interactions of complexes 1-4 with DNA and human serum albumin(HSA) were evaluated, and the cytotoxicity profiles of compounds 1-4 weredetermined using four different tumor cell lines derived from human cancers(melanoma: HT-144, colon: HCT-8, breast: MDA-MB-231 and lung: A549). A highercytotoxic activity was observed for compound (3) against non-small cell lungcancer (A549). Complex (3) inhibited the clonogenic capacity and cell cycleprogression of A549 cells and induced apoptosis involving mitochondrial pathwayactivation. Therefore, the data obtained in the present study support furtherinvestigations concerning molecular targets of complex (3) in non-small cell lungcancer.Copyright © 2018 Elsevier Inc. All rights reserved.DOI: 10.1016/j.jinorgbio.2018.06.008 PMID: 30015231 